Our story began with a shared vision: to bring advanced biotechnology to Pakistan and
improve access to life-changing medicines. What started as a partnership between Ferozsons
Laboratories Limited and Bagó has grown into Pakistan's first biotech formulation company,
setting new standards in manufacturing, quality, and innovation.
Today, we continue to build on that foundation—expanding our capabilities, investing in the
future of biotechnology, and developing medicines that improve the lives of patients at home
and around the world.
0+
Employees
0+
Products
0+
Therapeutic Areas
0+
Countries We Export To
A patient-centric healthcare organization focused on
addressing critical unmet medical needs in Pakistan
and international markets
“Through strategic partnerships and continued innovation, we aim to bring relevant healthcare solutions closer to patients and healthcare professionals in Pakistan.”
Mohammad Farhan
CEO BF Biosciences Limited
In 2020, BF Biosciences entered into a non-exclusive licensing agreement with
Gilead Sciences to manufacture and supply Remdesivir under Gilead's Global
Patient Solutions (GPS) Program. As the only company in Pakistan selected for
the program, BF Biosciences was licensed to manufacture and distribute the
antiviral treatment to up to 127 countries, supporting global efforts to improve
access to COVID-19 therapies, particularly in developing markets.
We are committed to employee development
through continuous learning and leadership
opportunities.
Latest Articles
At BF Biosciences, we believe healthcare is more than just prescriptions. It's about
compassion, innovation, and a deep commitment to improving lives across Pakistan.